Difference between the effect of atDCS and ctDCS for 4 weeks to improve hand function in patients with acute and subacute Stroke.
Not Applicable
- Conditions
- Health Condition 1: G819- Hemiplegia, unspecified
- Registration Number
- CTRI/2023/10/058749
- Lead Sponsor
- DVVPFs College of Physiotherapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with first ever Stroke in acute and subacute phase of recovery.
Spasticity ranging from (0-2) on modified Ashworth scale.
MMSE ranging between 28-30.
Patients with VCG of upper limb/hand of atleast grade 2.
Exclusion Criteria
Cerebellar or Brain Stem lesions.
Patients with presence of a metallic foreign body implant, such as a pacemaker.
Patients with history of seizure or another unstable medical condition.
Patients with visual impairment.
Patients underwent cranial surgery.
Hemiplegic shoulder pain.
Patients taking Na or Ca2 channel blockers or N-methyl-D-aspartate(NMDA) receptor antagonists.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Action Research Arm Test,Brunnstorm recovery stage for handTimepoint: baseline, 1 week, 2 week, 4 week
- Secondary Outcome Measures
Name Time Method Chadoke-Mcmaster Stroke AssessmentTimepoint: Baseline,1 week,2 week,4 week